Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: Elio Madama who wrote (2999)	2/6/1999 11:37:00 AM
From: Elio Madama	Respond to of 4650

We have two very important shareholders of ADOT right here who can help us all a lot about Biomoda. Guy, a Biomoda Rep. in Israel, who not only knows the kind of news we're getting on Monday, but nobody than him to give us a very good lesson about the company itself. Nutbuster, a doctor, who can teach us about the company progress in the lung cancer test kit, and many other things, good and bad about Biomoda. How about if these two investors share some information with us now, this weekend, before the news come out. Doctor, do you agree with Biomoda Chief Technical Officer, Doctor Jeff Garwin about the Biomoda technology would be capable of detecting early stages of pre-cancerous conditions of the lung? With ADOT owning 22.8% and BNEZ 250.000 shares of Biomoda, will be the test kit a success in the market? I am going to see if my son can help me about this today. The button line here is to determine how good or bad our investment is in ADOT and what are the possibilities of trading our stock in the near future $1.00 and over. Yes, ONE DOLLAR OR MORE, high risk companies must have a high return to take chances or it's not worth the risk. IMO. Elio